Fuzheng Jiedu granules for high-risk adults with COVID-19: A randomized, double-blind, placebo-controlled, multi-centre trial
{{output}}
Background: Fuzheng Jiedu granules (FZJD) is widely used for COVID-19 in China, with early studies indicating reduced mortality in severe cases. However, with emerging variants and shifted treatment focus on preventing severity a... ...
